MDxHealth S.A.

NASDAQ: MDXH · Real-Time Price · USD
2.89
0.05 (1.76%)
At close: Aug 15, 2025, 9:57 AM

MDxHealth S.A. Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
98.95M 94.51M 90.05M 84.71M 80.74M 75.33M 70.19M 63.69M 55.49M 45.65M 37.05M 30.18M 24.52M 23.29M 22.24M 20.52M 19.31M 18.58M
Cost of Revenue
36.09M 35.92M 36.03M 34.66M 32.42M 30.3M 27.39M 25.2M 23.34M 20.56M 17.84M 15.55M 13.55M 12.41M 11.83M 11.06M 10.74M 10.5M
Gross Profit
62.86M 58.58M 54.02M 50.04M 48.32M 45.02M 42.8M 38.48M 32.15M 25.09M 19.22M 14.63M 10.97M 10.88M 10.41M 9.46M 8.57M 8.08M
Operating Income
-17.2M -22.71M -24.73M -26.62M -25.09M -25.42M -27.52M -29.97M -37.34M -38.77M -37.9M -36.2M -31.42M -28.93M -26.84M -26.52M -26.3M -26.12M
Interest Income
889K 1.11M 1.79M 1.79M 2.16M 3.32M 1.95M 1.99M 1.49M 125K 125K 86K 28K 1K 1K 1K n/a n/a
Pretax Income
-26.72M -38.25M -37.69M -41.61M -40.8M -39.9M -43.1M -44.69M -48.28M -47.48M -44.04M -39.82M -33.81M -31.09M -29M -28.4M -28.25M -27.99M
Net Income
-34.61M -38.77M -38.07M -41.95M -40.8M -39.9M -46.09M -47.81M -51.27M -50.48M -44.46M -40.11M -34.23M -31.51M -29M -28.4M -28.25M -27.99M
Selling & General & Admin
67.07M 64.06M 63.78M 61.8M 60.22M 59.09M 58.3M 59.48M 60.58M 55.81M 50.12M 19.89M 12.15M 8.43M 7.65M 30.69M 30.13M 31.08M
Research & Development
7.98M 10.89M 10.55M 9.59M 9.25M 8.8M 8.74M 8.71M 8.53M 7.88M 7.56M 8.1M 7.43M 8.46M 8.34M 7.2M 6.9M 5.15M
Other Expenses
5.02M 6.34M 4.41M 1.51M 199K -1.13M -403K 324K 439K 168K -559K 22.85M 22.8M 9.46M -4.15M -27.16M -39.35M -25.73M
Operating Expenses
80.07M 81.29M 78.75M 76.67M 73.41M 70.44M 70.32M 68.45M 69.49M 63.86M 57.12M 50.83M 42.39M 39.39M 37.25M 36.15M 35.34M 35.08M
Interest Expense
12.79M 11.52M 9.62M 9.62M 10.71M 9.33M 9.04M 12.32M 8.03M 8.72M 6.14M 3.62M 2.33M 2.11M 2.16M 1.74M 1.61M 1.48M
Selling & Marketing Expenses
30.14M 40.77M 40.98M 10.23M 9M 7.96M 7.37M 37.38M 35.76M 31.59M 26.58M 7.63M 4.19M 7.01M 3.23M 17.43M 17.31M 13.23M
Cost & Expenses
116.16M 117.21M 114.78M 111.33M 105.83M 100.74M 97.71M 93.65M 92.83M 84.41M 74.95M 66.38M 55.94M 51.8M 49.08M 47.21M 46.08M 45.58M
Income Tax Expense
519K 519K 382K 335K 1K 1K 2.99M 3.12M 2.99M 2.99M 418K 290K 419K 418K n/a 336.25K 336.25K 336.25K
Shares Outstanding (Basic)
n/a 48.47M 48.86M 27.97M 27.29M 27.29M 27.29M 27.04M 27.04M 23.42M 12.19M 12.19M 12.19M 12.19M 12.19M 12.19M 11.86M 10.3M
Shares Outstanding (Diluted)
n/a 48.47M 48.86M 47.29M 27.29M 27.29M 27.29M 27.04M 27.04M 23.42M 12.19M 12.19M 12.19M 12.19M 12.19M 12.19M 11.86M 10.3M
EPS (Basic)
-0.88 -1.15 -1.27 -1.52 -1.49 -1.46 -1.78 -2.41 -3.15 -3.57 -3.47 -3.11 -2.63 -2.42 -2.49 -2.66 -2.86 -3.16
EPS (Diluted)
-0.72 -0.99 -1.11 -1.36 -1.49 -1.46 -1.78 -2.41 -3.15 -3.57 -3.65 -3.29 -2.81 -2.6 -2.49 -2.66 -2.86 -3.16
EBITDA
-7.46M -13.43M -16.49M -19.44M -18.39M -21.62M -24M -29.13M -37.07M -36.57M -36.56M -32.79M -28.59M -26.16M -24.63M -23.55M -23.22M -22.95M
EBIT
-16.32M -21.82M -24.52M -26.22M -24.89M -28.29M -30.41M -36.64M -44.01M -42.33M -41.47M -36.47M -31.69M -29.23M -27.14M -26.52M -26.3M -26.12M
Depreciation & Amortization
8.85M 8.39M 8.04M 6.97M 6.69M 6.67M 6.4M 7.31M 6.75M 5.76M 4.91M 3.68M 3.1M 3.07M 2.51M 2.97M 3.08M 3.17M